参考文献/References:
［1］Stein I F, Leventhal M L. Amenorrhea associated with bilateral polycystic ovaries ［J］. American Journal of Obstetrics&Gynecology, 1935, 29 (2): 181-191.
［2］Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome ［J］. Fertility and Sterility, 2016, 106 (1): 6-15.
［3］Zawadski JK，Dunaif A．Diagnostic criteria for polycystic ovary syndrome，towards a rational approach［A］∥Dunaif A，Givens JR，HasehineF．Polycystic Ovary Syndrome［M］．Boston：Blackwell Scientic，1992：377-384．
［4］Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome ［J］. Fertility and Sterility, 2004, 81(1): 19-25.
［5］Welt C K, Carmina E. Clinical review:Lifecycle of polycystic ovary syndrome(PCOS):from in utero to menopause ［J］. Journal of Clinical Endocrinology & Metabolism,2013,98(12):4629-4638.
［6］Brown Z A, Louwers Y V, FONG S L, et al. The phenotype of polycystic ovary syndrome ameliorates with aging ［J］. Fertility and Sterility, 2011, 96 (5): 1259-1265.
［7］Royal college of Obstetricians and Gynecologists.Long-term consequence of PCOS, Green-top Guideline No.33［EB/OL］.www.nice.org.uk/accreditation.
［8］Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group ［J］.Fertility and Sterility,2012,27(1):14-24.
［9］Wiksten‐Almstrmer M L, Hagenfeldt K. Prospective follow‐up of menstrual disorders in adolescence and prognostic factors ［J］. Acta Obstetricia et Gynecologica Scandinavica, 2011, 87 (11): 1162-1168.
［10］Conway G, Dewailly D, Diamanti-Kandarakis E, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology ［J］. European Journal of Endocrinology, 2014, 171 (4):1-29.
［11］Teede H J, Misso M L, Costello M F, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome ［J］. Fertility and Sterility, 2018, 110 (3): 364-379.
［12］The American College of Obstetricians and Gynecologists.ACOG PRACTICE BULLETIN Polycystic Ovary Syndrome Number 194.June 2018 ［J］.OBSTERICS&GYNECOLOGY，2018，131（6）：157-171．
［13］Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline ［J］. The Journal of Clinical Endocrinology and Metabolism, 2006, 91 (11): 4237-4245.
［14］Legro R S, Arslanlan S A, Ehrmann D A, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline ［J］.The Journal of Clinical Endocrinology and Metabolism,2013,98 (12):4565-4592.
［15］郁琦．多囊卵巢综合征诊治标准专家共识 ［J］．中国实用妇科与产科杂志，2007，23 （6）：474．
［16］中华医学会妇产科学分会内分泌学组. 多囊卵巢综合征的诊断和治疗专家共识［J］.中华妇产科杂志,2008，43(7):553-555.
［17］山东大学附属省立医院、中国医学科学院北京协和医院、南京医科大学第一附属医院等．多囊卵巢综合征诊断中华人民共和国卫生行业标准 ［J］．中华妇产科杂志，2012，47（1）：74-75．
［18］全国卫生产业企业管理协会妇幼健康产业分会生殖内分泌. 青春期多囊卵巢综合征诊治共识 ［J］.生殖医学杂志, 2016. 25 (9): 767-770.
［19］中华医学会妇产科学分会内分泌学组及指南专家组、多囊卵巢综合征中国诊疗指南［J］.中华妇产科杂志,2018，53(1):2-6.
［20］Garbedian, K. Effect of vitamin D status on clinical pregnancy rates following in vitro fertilization ［J］. Cmaj Open, 2013, 1 (2): 77-82.
［21］ZHAO Juan, LIU Shan, WANG Yi-dan, et al. Vitamin D improves in-vitro fertilization outcomes in infertile women with polycystic ovary syndrome and insulin resistance ［J］. Minerva Medica, 2019, 110 (3): 199-208.
相似文献/References:
[1]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[2]任涛,熊小英,蔡春芳,等.多囊卵巢综合征患者视黄醇结合蛋白-4的水平变化及意义[J].中国计划生育和妇产科,2013,(04):0.
REN Tao *,XIONG Xiao-ying,CAI Chun-fang.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]龚衍,曾玖芝,李运星,等.不同剂量来曲唑对多囊卵巢综合征不孕症患者诱导排卵的临床观察[J].中国计划生育和妇产科,2013,(05):0.
GONG Yan,ZENG Jiu-zhi,Li Yun-xing,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[4]李琳.无生育要求多囊卵巢综合征患者无排卵的处理[J].中国计划生育和妇产科,2014,(04):0.
LI Lin,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[5]刘振腾,郝翠芳.有生育要求的多囊卵巢综合征患者的治疗[J].中国计划生育和妇产科,2014,(04):0.
LIU Zhen-teng,HAO Cui-fang,Reproductive Medical Center,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[6]李淑红.腹腔镜下卵巢表面电凝术治疗多囊卵巢综合征的疗效分析[J].中国计划生育和妇产科,2014,(04):0.
LI Shu-hong,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[7]倪仁敏,杨冬梓.多囊卵巢综合征的发病概况[J].中国计划生育和妇产科,2014,(06):0.
[8]崔琳琳,陈子江.多囊卵巢综合征的临床诊断要点[J].中国计划生育和妇产科,2014,(06):0.
[9]刘义.多囊卵巢综合征长期管理与治疗策略[J].中国计划生育和妇产科,2014,(06):0.
[10]李尚为.多囊卵巢综合征的促排卵治疗[J].中国计划生育和妇产科,2014,(06):0.